adenosine diphosphate has been researched along with Atherosclerosis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 16 (55.17) | 29.6817 |
| 2010's | 12 (41.38) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, L; Fu, L; Li, B; Liu, H; Liu, Y; Yang, Y | 1 |
| Bernhagen, J; Bucala, R; Strüßmann, T; Tillmann, S; von Hundelshausen, P; Wirtz, T | 1 |
| Achenbach, S; Daniel, WG; Fan, Q; Garlichs, CD; Hintermann, C; Kurfürst, I; Losert, S; Pflederer, W; Raaz, D; Stumpf, C | 1 |
| Assinger, A; Butler, LM; Kral, JB; Kurzejamska, E; Mohammad, AA; Rahbar, A; Religa, P; Schabbauer, G; Schrottmaier, WC; Söderberg-Naucler, C; Wang, Y; Yaiw, KC | 1 |
| Durstberger, M; Eichelberger, B; Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S | 1 |
| Eichelberger, B; Gremmel, T; Kopp, CW; Koppensteiner, R; Panzer, S | 1 |
| Aalto, K; Hakovirta, H; Hollmén, M; Jalkanen, J; Jalkanen, S; Kiviniemi, T; Salomaa, V; Yegutkin, GG | 1 |
| Clark, T; Hajj-Ali, RA; Hoffman, GS; Langford, C; Major, J; Silverstein, RL; Sun, Z; Zhang, L | 1 |
| Baek, AE; Goonewardena, SN; Hyman, MC; Jo, H; Kanthi, Y; Liao, H; Neral, MK; Pinsky, DJ; Sutton, NR; Visovatti, SH | 1 |
| Cha, JK; Choi, JH; Huh, JT; Kang, MJ; Kim, DH; Nah, HW; Park, HS; Suh, HK | 1 |
| Kuehnl, P; Meinertz, T; Merten, M; Ruef, J | 1 |
| Bonifatius, S; Borgwardt, K; Gardemann, A | 1 |
| García, M; Schneider, DJ | 1 |
| Husted, S; van Giezen, JJ | 1 |
| Armstrong, M; Cannon, CP; Emanuelsson, H; Heptinstall, S; Husted, S; Lawrance, R; Melissa Thornton, S; Storey, RF; Wickens, M | 1 |
| Alamuddin, N; Crichton, I; FitzGerald, GA; Ibrahim, S; Lawson, JA; Prempeh, M; Puré, E; Rasmussen, LM; Ricciotti, E; Song, WL; Stubbe, J; Wilensky, RL | 1 |
| Bruno, V; Freynhofer, MK; Huber, K; Wojta, J | 1 |
| Deng, X; Fan, Y; Liu, X; Sun, A | 1 |
| Moliterno, DJ; Steinhubl, SR | 1 |
| Bingle, L; Brown, SB; Buttle, DJ; Dower, SK; Judge, HM; Sabroe, I; Storey, RF; Ward, JR; Whyte, MK | 1 |
| Boden, G; Rao, AK; Vaidyula, VR | 1 |
| Barakat, AI; Choi, HW; Ferrara, KW | 1 |
| Iwai, N; Niwa, Y | 1 |
| Brandl, R; Deckmyn, H; Penz, SM; Reininger, AJ; Siess, W; Toth, O | 1 |
| Fitzgerald, DJ; Maree, AO | 1 |
| Heim, HK; Hohlfeld, T; Schrör, K; Schumacher, M; Weber, AA | 1 |
| Gachet, C | 1 |
| Krishnan, LK; Ravindran, R | 1 |
| Bergmeier, W; Bernimoulin, M; Dole, VS; Krieger, M; Matuskova, J; Vasile, E; Wagner, DD; Yesilaltay, A | 1 |
5 review(s) available for adenosine diphosphate and Atherosclerosis
| Article | Year |
|---|---|
Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist.
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Diphosphate; Animals; Atherosclerosis; Clinical Trials as Topic; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine; Vasoconstriction | 2009 |
The role of platelets in athero-thrombotic events.
Topics: Adenosine Diphosphate; Animals; Atherosclerosis; Blood Platelets; Coronary Artery Disease; Coronary Thrombosis; Fibrinolytic Agents; Hemostasis; Humans; Plaque, Atherosclerotic; Platelet Activation; Platelet Aggregation Inhibitors; Thrombin; Thrombosis; Thromboxane A2 | 2012 |
The role of the platelet in the pathogenesis of atherothrombosis.
Topics: Adenosine Diphosphate; Animals; Atherosclerosis; Blood Coagulation; Blood Platelets; CD40 Ligand; Collagen; Humans; Myocardial Ischemia; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombin; Thrombosis | 2005 |
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
Topics: Adenosine Diphosphate; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Atherosclerosis; Biomarkers; Biotransformation; Blood Coagulation Tests; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Drug Interactions; Drug Resistance; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Thromboxane A2; Thromboxane B2; Ticlopidine; Treatment Failure | 2007 |
P2 receptors, platelet function and pharmacological implications.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Atherosclerosis; Blood Coagulation; Blood Platelets; Fibrinolytic Agents; Humans; Inflammation; Membrane Proteins; Mice; Mice, Knockout; Neovascularization, Physiologic; Platelet Activation; Polymorphism, Genetic; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Signal Transduction; Thrombosis | 2008 |
4 trial(s) available for adenosine diphosphate and Atherosclerosis
| Article | Year |
|---|---|
Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3.
Topics: Adenosine; Adenosine Diphosphate; Area Under Curve; Atherosclerosis; Clopidogrel; Dose-Response Relationship, Drug; Humans; Integrin beta3; Pharmacogenetics; Platelet Aggregation; Polymorphism, Single Nucleotide; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine | 2009 |
Niacin and biosynthesis of PGD₂by platelet COX-1 in mice and humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Atherosclerosis; Blood Platelets; Carotid Artery Thrombosis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Male; Membrane Proteins; Mice; Mice, Knockout; Platelet Activation; Platelet Aggregation Inhibitors; Prostaglandin D2; Receptors, G-Protein-Coupled; Receptors, Immunologic; Receptors, LDL; Receptors, Nicotinic; Receptors, Prostaglandin; Thromboxane A2 | 2012 |
Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects.
Topics: Adenosine Diphosphate; Adult; Atherosclerosis; Blood Platelets; Blood Proteins; Diabetes Complications; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Hyperinsulinism; Inflammation; Macrophage Activation; Male; Monocytes; Peptide Fragments; Platelet Aggregation | 2006 |
Effects of selective cyclooxygenase isoform inhibition on systemic prostacyclin synthesis and on platelet function at rest and after exercise in healthy volunteers.
Topics: Adenosine Diphosphate; Adult; Aspirin; Atherosclerosis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Endothelium; Epoprostenol; Exercise; Humans; Isoenzymes; Lactones; Male; Platelet Activation; Rest; Risk Factors; Sulfones; Thrombosis; Thromboxane B2 | 2007 |
20 other study(ies) available for adenosine diphosphate and Atherosclerosis
| Article | Year |
|---|---|
A Collagen-Derived Oligopeptide from Salmo salar Collagen Hydrolysates Restrains Atherogenesis in ApoE
Topics: Adenosine Diphosphate; Animals; Atherosclerosis; Collagen; Endothelial Cells; Mice; Mice, Knockout, ApoE; Molecular Docking Simulation; Oligopeptides; Phosphatidylinositol 3-Kinases; Salmo salar; Thrombosis | 2022 |
Platelets are a previously unrecognised source of MIF.
Topics: Adenosine Diphosphate; Animals; Antibodies, Blocking; Atherosclerosis; Blood Platelets; Cell Line; Cell Movement; Cell Separation; Chemokine CXCL12; Collagen; Flow Cytometry; Humans; Inflammation Mediators; Intramolecular Oxidoreductases; Lipoproteins, LDL; Macrophage Migration-Inhibitory Factors; Mice; Mice, Inbred C57BL; Monocytes; Protein Transport; Thrombin | 2013 |
Anti-inflammatory effects of danshen on human vascular endothelial cells in culture.
Topics: Abietanes; Adenosine Diphosphate; Anti-Inflammatory Agents; Atherosclerosis; Benzofurans; Blood Platelets; CD40 Antigens; Cells, Cultured; Chemokine CCL2; Down-Regulation; Drugs, Chinese Herbal; Human Umbilical Vein Endothelial Cells; Humans; Hydroxybenzoates; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; P-Selectin; Salvia miltiorrhiza; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2013 |
Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses.
Topics: Adenosine Diphosphate; Animals; Atherosclerosis; Blood Platelets; CD40 Ligand; Cell Degranulation; Cells, Cultured; Cytomegalovirus; Humans; Inflammation; Inflammation Mediators; Interleukin-1beta; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Neutrophil Activation; Neutrophils; Platelet Activation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2; Signal Transduction; Time Factors; Toll-Like Receptor 2; Transendothelial and Transepithelial Migration; Vascular Endothelial Growth Factor A | 2014 |
Human neutrophil α-defensins are associated with adenosine diphosphate-inducible neutrophil-platelet aggregate formation and response to clopidogrel in patients with atherosclerosis.
Topics: Adenosine Diphosphate; alpha-Defensins; Atherosclerosis; C-Reactive Protein; Clopidogrel; Flow Cytometry; Humans; Interleukin-6; Neutrophils; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine | 2014 |
Sex differences of leukocyte-platelet interactions and on-treatment platelet reactivity in patients with atherosclerosis.
Topics: Adenosine Diphosphate; Aged; Animals; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Female; Flow Cytometry; Humans; Integrin beta3; Leukocytes; Male; Mice; Middle Aged; Oligopeptides; P-Selectin; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoprotein IIb; Sex Factors | 2014 |
Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Triphosphate; Adult; Age Factors; Aged; Aged, 80 and over; Alkaline Phosphatase; Angiotensin-Converting Enzyme Inhibitors; Antigens, CD; Apyrase; Artifacts; Atherosclerosis; Biomarkers; Chronic Disease; Comorbidity; Disease Progression; Drug Utilization; Female; Finland; GPI-Linked Proteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoxia; Male; Middle Aged; Models, Cardiovascular; Peripheral Arterial Disease; Purinergic P2Y Receptor Antagonists; Risk Factors; Second Messenger Systems; Smoking; Thrombophilia | 2015 |
The interface of inflammation and subclinical atherosclerosis in granulomatosis with polyangiitis (Wegener's): a preliminary study.
Topics: Adenosine Diphosphate; Adult; Atherosclerosis; Blood Platelets; Blood Pressure; Carotid Intima-Media Thickness; Cell-Derived Microparticles; Cohort Studies; Demography; Diastole; Female; Granulomatosis with Polyangiitis; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Middle Aged; Platelet Aggregation; Recurrence; Regression Analysis; Risk Factors | 2015 |
Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Antigens, CD; Apolipoproteins E; Apyrase; Atherosclerosis; Blood Flow Velocity; Blood Platelets; Dietary Fats; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Human Umbilical Vein Endothelial Cells; Humans; Kruppel-Like Transcription Factors; Mice; Mice, Knockout; Plaque, Atherosclerotic; Platelet Activation; Response Elements; Shear Strength | 2015 |
High residual platelet reactivity (HRPR) for adenosine diphosphate (ADP) stimuli is a determinant factor for long-term outcomes in acute ischemic stroke with anti-platelet agents: The meaning of HRPR after ADP might be more prominent in large atherosclero
Topics: Adenosine Diphosphate; Atherosclerosis; Brain Ischemia; Cohort Studies; Endpoint Determination; Follow-Up Studies; Humans; Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Prognosis; Stroke; Treatment Outcome | 2016 |
The complement factor properdin induces formation of platelet-leukocyte aggregates via leukocyte activation.
Topics: Adenosine Diphosphate; Adult; Atherosclerosis; Blood Platelets; CD11b Antigen; Cell Adhesion; Cell Aggregation; Complement Pathway, Alternative; Humans; Leukocytes; P-Selectin; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Properdin | 2008 |
Acidic peptides enhanced genistein-dependent inhibition of human platelet aggregation: potential protective effect of digestible peptides plus genistein against atherosclerosis.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Atherosclerosis; Collagen; Dipeptides; Epinephrine; Female; Genistein; Humans; Male; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Soybean Proteins | 2008 |
Adenosine diphosphate-induced platelet aggregation correlates with platelet activation identified with the use of flow cytometry.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Atherosclerosis; Female; Fibrinogen; Flow Cytometry; Humans; Male; Middle Aged; Nephelometry and Turbidimetry; Platelet Activation; Platelet Aggregation | 2008 |
Numerical simulation of nucleotide transport in the human thoracic aorta.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Aorta, Thoracic; Atherosclerosis; Biological Transport, Active; Biomechanical Phenomena; Computer Simulation; Endothelial Cells; Hemodynamics; Humans; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Male; Models, Cardiovascular; Pulsatile Flow | 2013 |
Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor.
Topics: Adenosine Diphosphate; Antibodies; Atherosclerosis; Blood Platelets; Calcium; Cell Line; Epinephrine; Humans; Lipopolysaccharides; Lipoproteins; Megakaryocytes; P-Selectin; Platelet Activating Factor; Platelet Activation; Platelet Membrane Glycoprotein IIb; Toll-Like Receptor 2; Toll-Like Receptor 4; Vasoconstrictor Agents | 2005 |
Modulation of ATP/ADP concentration at the endothelial surface by shear stress: effect of flow recirculation.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Atherosclerosis; Calcium Signaling; Computer Simulation; Endothelium, Vascular; Humans; Models, Cardiovascular; Pulsatile Flow; Stress, Mechanical | 2007 |
Nanomaterials induce oxidized low-density lipoprotein cellular uptake in macrophages and platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Atherosclerosis; Cell Line; Fullerenes; Lipoproteins, LDL; Macrophages; Mice; Nanostructures; Platelet Aggregation; Soot | 2007 |
Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Antibodies, Monoclonal; Aspirin; Atherosclerosis; Blood Coagulation Tests; Blood Platelets; Carotid Stenosis; Dose-Response Relationship, Drug; Hemorheology; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Thrombosis; Time Factors; von Willebrand Factor | 2007 |
Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
Topics: Adenosine Diphosphate; Atherosclerosis; Blood Platelets; Cell Size; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Collagen; Coronary Disease; Diabetes Complications; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Male; Membrane Lipids; Middle Aged; Platelet Aggregation; Platelet Count; Risk Factors; Smoking; Triglycerides | 2007 |
Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice.
Topics: Adenosine Diphosphate; Animals; Atherosclerosis; Blood Platelets; Cell Aggregation; Cholesterol; Disease Models, Animal; Female; Lipoproteins, HDL; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Lipoprotein; Scavenger Receptors, Class B; Thrombocytopenia | 2008 |